Objectives: To analyse the five-year survival of cervical cancer patients in Hospital Tuanku Fauziah, Kangar, Perlis.
Methods: A retrospective study involving patients with cervical cancer in Hospital Tuanku Fauziah, Kangar, Perlis. Data of cervical cancer patients from 1st January 2000 to 31st December 2011 were searched from oncology cards from clinic. An exclusion criterion was the missing data. The demographic data and survival rate according to stages, age, histology, presence of lymphadenopathy and treatment received by patients were analysed using SPSS. The survival probability was determined using Kaplan-Meier method. Permission was received from Ethical Committee HTF.
Results: 69 patients were identified. 43.5% (N=30), 34.8% (N=24), 7.2% (N=5) and 14.5% (N=10), were diagnosed at stage I, II, III and IV, respectively. Mean age at diagnosis was 54.5 year. Majority of the patients were Malay (75.4%) followed by Siamese (13%). Majority of cases were squamous cell carcinoma, 63.8% (N=44). Overall 5-year survival was 52.2% (N=36). Mean survival time was 131.7 (95% CI: 106.6, 156.8) months. Patients diagnosed at stage III & IV had poorer survival of 40% and 20%, respectively, as compared to stage I and II patients, with survival of 63.3% and 54.2%, correspondingly. The 5-year survival was higher in patients who received surgery as primary treatment (71%) compared to non-surgical group (29%).
Conclusion: The overall 5-year survival of cervical cancer in this study was 52.2%. The survival of those at early stage is better than advanced stage. Patients who underwent surgery as primary treatment had a better survival rate as compared to those who had no surgery done.